Meridian Investment Counsel’s Astera Labs ALAB Stock Holding History

Meridian Investment Counsel’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25M	Buy	+4,655	New	+$1.24M	0.48%	67

Other funds holding ALAB

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SIC

Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

VWS

Virtus Wealth Solutions Cranford, New Jersey $735M AUM 209.29% 1-Year Est. Return

SSA

Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

TEC

Tensor Edge Capital Weston, Massachusetts $1.51B AUM

MLCM

M & L Capital Management London, United Kingdom $370M AUM 165.61% 1-Year Est. Return

Meridian Investment Counsel's ALAB Position: Q2 2026 in Review

Meridian Investment Counsel opened a new position in Astera Labs (ALAB) in Q2 2026: 4,655 shares worth $2.25M. The stake represents 0.48% of the portfolio and ranks #67 among its holdings.

225 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Meridian Investment Counsel held 4,655 shares of Astera Labs worth $2.25M as of Q2 2026.
Astera Labs was a new Meridian Investment Counsel position in Q2 2026.
Astera Labs made up 0.48% of Meridian Investment Counsel's portfolio in Q2 2026, its #67 holding.
225 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.